Laura Weiler for STAT

Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin with 

In survey of NIH-funded researchers, 14% said immigration changes had forced scientists, students, postdocs to turn down jobs in their labs.

By Andrew Joseph

Opinion: Are blue zones real? Answering that question is harder than ever

Examining the science and growing commercialization of 'blue zones,' famed longevity hot spots that seem to be fading – if they ever existed at all.

By Shelley Wood and Eric J. Topol

Opinion: Mifepristone court ruling makes drug development riskier for everyone

Recent ruling on mifepristone abortion drug could unwind decades of scientific review and undermine the FDA.

By Grace Colón

Camille MacMillin/STAT

Researchers urge study of paternal deaths, though a new paper finds fatherhood is protective

JAMA Pediatrics paper explores paternal deaths in a child's first five years and finds that fatherhood is linked to reduced mortality.

By Annalisa Merelli

What to know about hantavirus, the illness suspected in a cruise ship outbreak

The disease gained attention last year after late actor Gene Hackman’s wife, Betsy Arakawa, died from a hantavirus infection in New Mexico.

By Associated Press

STAT+ | Biotech raises $42 million to run Huntington’s disease trial

Biotech startup, Latus Bio, raised $42 million as it prepares to seek FDA permission to start a clinical trial to test its gene therapy for Huntington's disease.

By Allison DeAngelis

Adobe

STAT+ | Opinion: China’s strict new supply chain regulations could create massive problems for Western biopharma companies

New regulations exploit the commercial indispensability that China’s pharmaceutical ecosystem has built over the past decade.

By Dennis Kwok